Parabilis Medicines appoints Dr. Craig L. Tendler to board
Parabilis Medicines (PBLS) appoints drug development leader Craig L. Tendler, M.D., to its board of directors.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.